{
    "type": "ETF",
    "ucits": true,
    "fund_name": "WisdomTree BioRevolution UCITS ETF - USD Acc",
    "investment_objective": "Track the price and yield performance of the WisdomTree BioRevolution ESG Screened Index, which measures global companies involved in BioRevolution activities across sectors such as Human Health, Agriculture and Food, Materials, Chemicals and Energy, and Biological Machines and Interfaces.",
    "primary_asset_class": "Equity",
    "geographic_focus": "Global, with majority exposure to the United States (~82%) and smaller allocations to Denmark, Germany, Switzerland, UK, Netherlands, Japan, Canada, Australia, Austria",
    "replication_method": "physical",
    "swaps": false,
    "derivatives": false,
    "leverage": false,
    "inverse": false,
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The ETF uses a physical, fully replicated method to track the WisdomTree BioRevolution ESG Screened Index, investing directly in equity securities representing the index constituents or a representative sample. There is no mention of synthetic replication, swap agreements, total return swaps, or derivative instruments as part of the investment strategy. The fund may engage in repurchase/reverse repurchase agreements and stock lending solely for efficient portfolio management, which is standard and does not imply complexity under MiFID II. The risk profile is medium (4 out of 7) in the PRIIPs KID, reflecting typical equity market risks and sector concentration, but no leverage or inverse exposure is present. The fund is UCITS compliant, physically backed, and invests in liquid, transparent securities. No capital protection or structured features are indicated. Costs are straightforward with a TER of 0.45%, no performance fees, and no swap or derivative fees. Counterparty risk disclosures relate to standard operational and custody risks, not to derivative counterparty exposure. The PRIIPs KID does not include any comprehension warnings or complexity flags. The index tracked is thematic but composed of listed equities meeting liquidity and ESG criteria, without complex structured products or contingent bonds. Therefore, the ETF does not meet MiFID II criteria for classification as complex."
}